Drugs / 188Re-PTI-6D2
last change Jun 2008 re-read 3 minutes ago

188Re-PTI-6D2

Developed for
metastatic melanoma
Investigated by
Pain Therapeutics

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00399113 May 2007 → Jun 2008 metastatic melanoma Pain Therapeutics Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 188Re-PTI-6D2 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00399113 ↗